http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60149522-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067bc5ace16106b2ed7bc6f1198d59ae
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-12
filingDate 1984-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81d2a92514e74d9539a90f7d1d30fded
publicationDate 1985-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S60149522-A
titleOfInvention Immunoactivating agent
abstract PURPOSE: To provide an immunoactivating or immunoregulating agent containing a specific indole derivative such as 5-hydroxytryptamine (5-HT), etc. n CONSTITUTION: The objective agent contains the compound of formula I [R is group of formula II (Y is H or carboxyl; m is 1W3), -(CH 2 ) n -COOH (n is 1W3), -CH 2 -C(O)-COOH, group of formula III, or -CHO; X is H or OH] or its salt, as an active component. It has been found that the 5-HT of formula IV known as a nerve impulse transmission substance in living body and the 5-hydroxytryptophan (5-HTP) of formula V known as a precursor to produce 5-HT by the action of 5-hydroxylase are effective to promote the damaging activity of lymphocyte T-cell to carcinoma cell in test tube, and that although 5-HT and 5- HTP have no activity to damage carcinoma cell, however, the compounds exhibit antitumor activity in the living body when administered to a cancer- carrying host. n COPYRIGHT: (C)1985,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2597339-A1
priorityDate 1984-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56605938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283

Total number of triples: 36.